<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "brentiximab inj VIAL">
<dose><value>1.8</value>
<value>1.2</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>50 mg</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction></instruction>
<volume></volume>
<units><value>mg/kg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Maximum dosing weight is 100 kg with a maximum dose of 180 mg. Recommend dosage reduction to 1.2 mg/kg in patients with mild hepatic impairment (Child-Pugh Class A) or patients with periperal neuropathy (new or worsening) Grade 2 or 3. </value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6601</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>